רפרנס:
1. National Comprehensive Cancer Network. Antiemesis (Version 1.2021). https://www.nccn.org/professionals/physician_gls/pd- .f/antiemesis.pdf. Accessed December 23, 2020
2. Electrocardiographic findings of palonosetron in cancer patients; G.Gonullu et al; Support Care Cancer 2011
3. Acute effect of palonosetron on electrocardiographic parameters in cancer patients: A prospective study; C. Yavas et al; Support Care Cancer 2011
4. Tricco AC, et al. BMC Med. 2016;14(1):216. doi: 10.1186
5. Boccia R, et al. Support Care Cancer. 2013 May;21(5):1453-60.
6. Cui J, Zhang Q, Zhang H, Spinelli T, Nicolas P, Li W. Oral versus intravenous palonosetron in Chinese cancer patients receiving moderately emetogenic chemotherapy: A non-inferiority phase III trial. Eur J Cancer Care (Engl). 2020 Jul;29(4):e13245. doi:10.1111/ecc.13245. Epub 2020 Jun 21. PMID: 32567124.
